The Role of MicroRNA in Regulation of Signaling Pathways in Gliomas


如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅存取

详细

Gliomas are invasive brain tumors characterized by high rates of recurrence and mortality. Glioblastoma multiforme (GBM) is the most aggressive form of glioma with nearly 100% rate of recurrence and unfavorable prognosis in patients. MicroRNAs (miR) are a class of wide-spread short noncoding RNAs that inhibit translation via binding to the mRNA of target genes. The aim of this review is to analyze studies and experimental results on changes in the expression profiles of microRNA which are characteristic for gliomas/ glioblastomas and targeted to components of signaling pathways Hedgehog, Notch, Wnt, EGFR, TGFβ, and HIF1α, aberrantly regulated in the gliomas. Special attention has been paid to the links of microRNA to the targets of 2-hydroxyglutarate, the product of mutant isocitrate dehydrogenase (R132H IDH1), mutational changes of which are specific for the pathogenesis of gliomas. Detection of certain types of microRNA in tissues and blood serum can be used for diagnostics and prediction, including responsiveness of individual patients to therapy, and development of new therapeutic strategies.

作者简介

O. Kit

Rostov Research Institute of Oncology

Email: tailana703@gmail.com
俄罗斯联邦, 14 Liniya 63, Rostov-on-Don, 344037

D. Vodolazhsky

Rostov Research Institute of Oncology

Email: tailana703@gmail.com
俄罗斯联邦, 14 Liniya 63, Rostov-on-Don, 344037

E. Rostorguev

Rostov Research Institute of Oncology

Email: tailana703@gmail.com
俄罗斯联邦, 14 Liniya 63, Rostov-on-Don, 344037

D. Porksheyan

Rostov Research Institute of Oncology

Email: tailana703@gmail.com
俄罗斯联邦, 14 Liniya 63, Rostov-on-Don, 344037

S. Panina

Rostov Research Institute of Oncology

编辑信件的主要联系方式.
Email: tailana703@gmail.com
俄罗斯联邦, 14 Liniya 63, Rostov-on-Don, 344037

补充文件

附件文件
动作
1. JATS XML

版权所有 © Pleiades Publishing, Ltd., 2018